A significant decline from baseline ( 10.9 % , p < 0.01 ) in the serum FGF23 concentration was observed in the ERN group compared to placebo , but not in the ERN-L group compared to placebo ( p = 0.36 and 0.97 for ERN-L and placebo , respectively ) , despite equivalent declines in serum phosphorus .